Besponsa
Drug timelines are a Plus or Pro feature.
30 regulatory and trial events tracked for Besponsa, covering 2015-12-09 to 2026-04-23. Get the full timeline:
Most recent: Clinical Trial Update: Study of Pedi-cRIB: Mini-Hyper-CVD With Condensed Rituximab, Inotuzumab Ozogamicin and Blinatumomab (cRIB) for Relapsed Therapy for Pediatric With B-Cell Lineage Acute Lymphocytic Leukemia [Phase 2]